Trisol Medical - About the company
Trisol Medical is a seed company based in Yokneam Illit (Israel), founded in 2016. It operates as a Percutaneous solution for tricuspid valve disease. Trisol Medical has raised $2.7M in funding. The company has 114 active competitors, including 51 funded and 29 that have exited. Its top competitors include companies like Shockwave Medical, MicroPort CardioFlow Medtech Corporation and Peijia Medical Technologies.
Company Details
Trisol Medical is focussed on developing solutions for valvular disorders. It is currently developing a percutaneous solution for tricuspid valve disease. It is currently being developed within the Alon Medical incubator and is in R&D stage.
Key Metrics
Founded Year
2016
Location
Yokneam Illit, Israel
Stage
Seed
Total Funding
$2.7M in 5 rounds
Latest Funding Round
Ranked
15th among 114 active competitors
Employee Count
25 as on Aug 31, 2026
Similar Companies
Sign up to download Trisol Medical's company profile
Trisol Medical's funding and investors
Trisol Medical has raised a total funding of $2.7M over 5 rounds. Its first funding round was on Sep 01, 2018. Its latest funding round was a Grant (prize money) round on Jan 31, 2022 for $*****. 1 investor participated in its latest round. Trisol Medical has 4 institutional investors.
Here is the list of recent funding rounds of Trisol Medical:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 31, 2022 | 3314774 | Grant (prize money) | 4818144 | 1101229 | 6379003 | 6937481 |
Feb 01, 2020 | 5399481 | Grant (prize money) | 6095896 | 6809868 | 7538910 | |
Dec 31, 2018 | 4213140 | Grant (prize money) | 3798723 | 4769187 | 6683684 |
Access funding benchmarks and valuations. Sign up today!View details of Trisol Medical's funding rounds and investors
Trisol Medical's founders and board of directors
Founder? Claim ProfileTrisol Medical's employee count trend
Trisol Medical has 25 employees as of Aug 26. Here is Trisol Medical's employee count trend over the years:
Uncover Trisol Medical's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Trisol Medical's Competitors and alternates
Top competitors of Trisol Medical include Shockwave Medical, MicroPort CardioFlow Medtech Corporation and Peijia Medical Technologies. Here is the list of Top 10 competitors of Trisol Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Shockwave Medical 2009, Santa Clara (United States), Acquired | Developer of cardiovascular balloon dilation catheters | $148M | 65/100 | |
2nd |  MicroPort CardioFlow Medtech Corporation 2015, Pudong (China), Public | Developer of smart medical devices for patients with heart valve diseases | $132M | 63/100 | |
3rd | Peijia Medical Technologies 2012, Suzhou (China), Public | Developer of medical devices for the treatment of cardiac and cerebrovascular diseases | $110M | 63/100 | |
4th | Cardiac Dimensions 2001, Kirkland (United States), Series E | Developer of invasive cardiac implants for heart failure | $261M | 62/100 | |
5th | JenaValve Technology 2006, Irvine (United States), Acquired | Provider of pericardial transcatheter aortic valve replacement and delivery system | $364M | 62/100 | |
6th | Venus MedTech 2009, Hangzhou (China), Public | Transcatheter aortic valves | $37M | 62/100 | |
7th | Developer of a percutaneous device for treating tricuspid regurgitation | $52.1M | 58/100 | ||
8th | Developer of a minimally invasive tricuspid valve replacement system. This system is designed to treat tricuspid regurgitation, a serious heart condition, without the need for open-heart surgery. The company focuses on developing a safe and effective solution to address the limitations of existing treatment approaches. It is developing a catheter-based system for tricuspid valve replacement. The company's efforts include clinical trials and securing funding to support further development and clinical milestones. | $103M | 58/100 | ||
9th |  HighLife Medical 2010, Paris (France), Series B | Developer of trans-catheter mitral valve replacement system | $50.8M | 56/100 | |
10th | Innovheart 2015, Milano (Italy), Series C | Provider of aesthetic devices for the treatment of atrioventricular valve diseases | $78.7M | 56/100 | |
15th | Trisol Medical 2016, Yokneam Illit (Israel), Seed | Percutaneous solution for tricuspid valve disease | $2.7M | 51/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Trisol Medical's competitors? Click here to see the top ones
Trisol Medical's Investments and acquisitions
Trisol Medical has made no investments or acquisitions yet.
Reports related to Trisol Medical
Here is the latest report on Trisol Medical's sector:
News related to Trisol Medical
Media has covered Trisol Medical for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Heart Valve SystemBusinessFortNight•Jan 21, 2026•Trisol Medical
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Trisol Medical
Explore our recently published companies
- The Good Bread - Minneapolis based, 1973 founded, Unfunded company
- Erin McDonough - Unfunded company
- Cocly Design - Unfunded company
